Learn · Part 5. Special situations · 4 min read
Body habitus, sex and the choice of test
What the sources say about obesity, breast tissue and sex for image quality, radiation and test choice.
60-second take
- Body size affects each test differently: poor echo windows, SPECT attenuation artifact, reduced CCTA quality in morbid obesity. The PET documents say PET is less affected by body habitus or sex.
- Obesity-specific recommendations come mostly from nuclear documents. The 2023 AUC did not split its ratings by body size and says its ratings are not rankings.
- For women, the ASE and PET documents point to different tests (echo for no radiation and no breast attenuation, PET for accuracy and dose). Local expertise and the individual patient decide.
- In low-risk premenopausal women the AUC says to consider testing without radiation, or no testing. In pregnancy, avoid ionizing radiation where possible.
- We found no source for MRI bore or table-weight limits. Ask the imaging lab.
Body size and image quality
A test is only useful if the pictures or tracings are good enough to read. The 2021 chest pain guideline says this plainly: for every imaging test, the chance of getting high-quality images should be weighed up, particularly in people with obesity . It adds that imaging people with a body mass index (BMI) above 40 kg/m² can be challenging and calls for careful thought about the equipment available .
The sources describe the problem differently for each test. Here is what they say, and only what they say.
| Test | What the sources say about size |
|---|---|
| Exercise ECG | BMI above 40 kg/m² is listed among the disabling conditions that can stop someone being a candidate for treadmill testing . |
| Stress echo | Limited acoustic windows are the listed limitation, with obesity as one cause . Ultrasound enhancing agents have greatly improved image quality, and the ASE guideline recommends them when two or more neighbouring segments, or any coronary territory, cannot be seen well . |
| SPECT | Attenuation, motion and soft-tissue artifacts may lead to the extent of disease being underestimated . |
| PET | The ASNC position statement says PET’s usefulness is not affected by sex or body habitus . The PET AUC argues that, in people with advanced obesity (BMI around 35 kg/m² and above), PET offers the highest diagnostic accuracy and the lowest radiation exposure among the nuclear techniques . |
| CCTA | Image quality may be reduced in morbid obesity, with fast or irregular heart rates, and with severe coronary calcium . |
| Stress CMR | The documents we reviewed give no size, bore or table-weight limits. Those depend on the scanner, so the imaging lab is the place to ask. |
Stress testing itself is commonly done safely in people with obesity. The ASNC stress guideline asks teams to check the treadmill and camera weight and size limits, and says that if every stressor is feasible, exercise remains the preferred one .
What the PET documents add
Several documents lean toward PET when PET is available. The 2021 chest pain guideline and the 2023 chronic coronary disease guideline both say that when nuclear perfusion imaging is chosen, PET is reasonable in preference to SPECT, to improve accuracy and reduce nondiagnostic results (class 2a, for people with stable symptoms and no known disease, or with known obstructive disease) . Neither makes this obesity-specific. The ASNC stress guideline does: it recommends PET over SPECT in people with obesity .
Sex, and women in particular
The sources raise four separate points about women. They are easy to blur together.
- Radiation in low-risk premenopausal women. The AUC says testing without radiation, or no testing, should be considered .
- Breast tissue. The ASE guideline gives a class I recommendation for stress echo as the preferred test in women, citing no radiation to the breasts and no breast attenuation artifact . The PET AUC, for women with large or dense breasts, argues that PET has the highest diagnostic accuracy among noninvasive imaging modalities and the lowest radiation exposure, in particular to the breast .
- Risk estimates. Older pretest-probability scores overestimate the chance of obstructive disease in contemporary patients, particularly women .
- Exercise testing. In the WOMEN trial of low-risk symptomatic women, exercise ECG alone was an effective strategy compared with exercise perfusion imaging, with no significant difference in death from coronary disease or hospitalization for acute coronary syndrome or heart failure, and significant cost savings .
Note that the ASE and PET documents point to different tests for the same group of women. That is not an error. Each society documents the strengths of its own method, and the AUC deliberately does not pick between them.
The 2023 AUC counts diabetes among the cardiovascular risk factors used in its symptomatic scenarios , and lists diabetes with accelerated coronary disease among the features of people at higher risk for silent ischemia .
The PET AUC has scenarios specific to people with diabetes. Its reasoning is that PET assesses obstructive disease and microvascular dysfunction in one study, and that the microvascular finding adds diagnostic and prognostic value in this high-risk group. For asymptomatic people with diabetes, it describes the value of stress-rest perfusion imaging as controversial .
The scenario builder does not take diabetes as a separate input beyond its role as a risk factor, and we have not added claims the sources do not make.
Open the scenario builder → and use the patient factors for advanced obesity, large or dense breasts, or poor echo windows to see how they are carried alongside the ratings.
Try it in the tool
Sources cited on this page
Click a tag for the full reference. All references